AAAAAA
Results: 51-75/91
Authors:
STAM TC
JONGENLAVRENCIC M
EGGERMONT AMM
SWAAK AJG
Citation: Tc. Stam et al., EFFECTS OF ISOLATED LIMB PERFUSION WITH TUMOR-NECROSIS-FACTOR-ALPHA ON THE FUNCTION OF MONOCYTES AND T-LYMPHOCYTES IN PATIENTS WITH CANCER, European journal of clinical investigation, 26(12), 1996, pp. 1085-1091
Authors:
MANUSAMA ER
NOOIJEN PTGA
STAVAST J
DURANTE NMC
MARQUET RL
EGGERMONT AMM
Citation: Er. Manusama et al., SYNERGISTIC ANTITUMOR EFFECT OF RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR-ALPHA WITH MELPHALAN IN ISOLATED LIMB PERFUSION IN THE RAT, British Journal of Surgery, 83(4), 1996, pp. 551-555
Authors:
KRUIT WHJ
PUNT CJA
GOEY SH
DEMULDER PHM
GRATAMA JW
EGGERMONT AMM
BOLHUIS RLH
STOTER G
Citation: Whj. Kruit et al., DOSE EFFICACY STUDY OF 2 SCHEDULES OF HIGH-DOSE BOLUS ADMINISTRATION OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN METASTATIC MELANOMA, British Journal of Cancer, 74(6), 1996, pp. 951-955
Authors:
NOOIJEN PTGA
MANUSAMA ER
EGGERMONT AMM
SCHALKWIJK L
STAVAST J
MARQUET RL
DEWAAL RMW
RUITER DJ
Citation: Ptga. Nooijen et al., SYNERGISTIC EFFECTS OF TNF-ALPHA AND MELPHALAN IN AN ISOLATED LIMB PERFUSION MODEL OF RAT SARCOMA - A HISTOPATHOLOGICAL, IMMUNOHISTOCHEMICAL AND ELECTRON-MICROSCOPIC STUDY, British Journal of Cancer, 74(12), 1996, pp. 1908-1915
Authors:
EGGERMONT AMM
KOOPS HS
KLAUSNER JM
KROON BBR
SCHLAG PM
LIENARD D
VANGEEL AN
HOEKSTRA HJ
MELLER I
NIEWEG OE
KETTELHACK C
BENARI G
PECTOR JC
LEJEUNE FJ
Citation: Amm. Eggermont et al., ISOLATED LIMB PERFUSION WITH TUMOR-NECROSIS-FACTOR AND MELPHALAN FOR LIMB SALVAGE IN 186 PATIENTS WITH LOCALLY ADVANCED SOFT-TISSUE EXTREMITY SARCOMAS - THE CUMULATIVE MULTICENTER EUROPEAN EXPERIENCE, Annals of surgery, 224(6), 1996, pp. 756-765
Authors:
CANEVARI S
STOTER G
ARIENTI F
BOLIS G
COLNAGHI MI
DIRE EM
EGGERMONT AMM
GOEY SH
GRATAMA JW
LAMERS CHJ
NOOY MA
PARMIANI G
RASPAGLIESI F
RAVAGNANI F
SCARFONE G
TRIMBOS JB
WARNAAR SO
BOLHUIS RLH
Citation: S. Canevari et al., REGRESSION OF ADVANCED OVARIAN-CARCINOMA BY INTRAPERITONEAL TREATMENTWITH AUTOLOGOUS T-LYMPHOCYTES RETARGETED BY A BISPECIFIC MONOCLONAL-ANTIBODY, Journal of the National Cancer Institute, 87(19), 1995, pp. 1463-1469
Authors:
NOOTER K
WESTERMAN AM
FLENS MJ
ZAMAN GJR
SCHEPER RJ
VANWINGERDEN KE
BURGER H
OOSTRUM R
BOERSMA T
SONNEVELD P
GRATAMA JW
KOK T
EGGERMONT AMM
BOSMAN FT
STOTER G
Citation: K. Nooter et al., EXPRESSION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) GENE IN HUMAN CANCERS(1), Clinical cancer research, 1(11), 1995, pp. 1301-1310
Authors:
KLEEBERG UR
EGGERMONT AMM
Citation: Ur. Kleeberg et Amm. Eggermont, 25 YEARS OF PLURIDISCIPLINARY APPROACH FOR MELANOMA PATIENTS - THE EUROPEAN ORGANIZATION ON RESEARCH AND TREATMENT OF CANCER MELANOMA COOPERATIVE GROUP (EORTC-MCG), Melanoma research, 5(1), 1995, pp. 69-72
Authors:
EGGERMONT AMM
KOOPS HS
KROON BBR
KLAUSNER JM
SCHLAG PM
LEJEUNE FJ
Citation: Amm. Eggermont et al., THE EUROPEAN EXPERIENCE IN TNF-ALPHA ISOLATED LIMB PERFUSIONS FOR NONRESECTABLE EXTREMITY SOFT-TISSUE SARCOMAS - 85-PERCENT RESPONSE RATE, 87-PERCENT LIMB SALVAGE, European journal of cancer, 31A, 1995, pp. 217-217
Authors:
KEILHOLZ U
EGGERMONT AMM
Citation: U. Keilholz et Amm. Eggermont, A RANDOMIZED TRIAL OF IFN-ALPHA AND IL-2+ -CISPLATINUM IN ADVANCED MELANOMA - A PRELIMINARY-ANALYSIS/, European journal of cancer, 31A, 1995, pp. 43-43
Authors:
KLAASE JM
KROON BBR
EGGERMONT AMM
VANGEEL AN
KOOPS HS
OLDHOFF J
LIENARD D
LEJEUNE FJ
BERKEL R
FRANKLIN HR
HART AAM
Citation: Jm. Klaase et al., A RETROSPECTIVE COMPARATIVE-STUDY EVALUATING THE RESULTS OF MILD HYPERTHERMIC VERSUS CONTROLLED NORMOTHERMIC PERFUSION FOR RECURRENT MELANOMA OF THE EXTREMITIES, European journal of cancer, 31A(1), 1995, pp. 58-63
Authors:
SIJENS PE
EGGERMONT AMM
VANDIJK P
OUDKERK M
Citation: Pe. Sijens et al., P-31 MAGNETIC-RESONANCE SPECTROSCOPY AS PREDICTOR OF CLINICAL-RESPONSE IN HUMAN EXTREMITY SARCOMAS TREATED BY SINGLE-DOSE TNF-ALPHA PLUS MELPHALAN ISOLATED LIMB PERFUSION, NMR in biomedicine, 8(5), 1995, pp. 215-224
Authors:
VANROOZENDAAL CEP
KLIJN JGM
VANOOIJEN B
CLAASSEN C
EGGERMONT AMM
HENZENLOGMANS SC
FOEKENS JA
Citation: Cep. Vanroozendaal et al., TRANSFORMING GROWTH-FACTOR-BETA SECRETION FROM PRIMARY BREAST-CANCER FIBROBLASTS, Molecular and cellular endocrinology, 111(1), 1995, pp. 1-6
Authors:
EGGERMONT AMM
Citation: Amm. Eggermont, SURVEY OF STAGE-I MELANOMA PATIENTS AFTER EXCISION OF THE PRIMARY TUMOR, Annales de dermatologie et de venereologie, 122(5), 1995, pp. 292-297
Authors:
RENARD N
NOOIJEN BTGA
SCHALKWIJK L
DEWAAL RMW
EGGERMONT AMM
LIENARD D
KROON BBR
LEJEUNE FJ
RUITER DJ
Citation: N. Renard et al., VWF RELEASE AND PLATELET-AGGREGATION IN HUMAN-MELANOMA AFTER PERFUSION WITH TNF-ALPHA, Journal of pathology, 176(3), 1995, pp. 279-287
Authors:
GOEY SH
EGGERMONT AMM
PUNT CJA
SLINGERLAND R
GRATAMA JW
OOSTEROM R
OSKAM R
BOLHUIS RLH
STOTER G
Citation: Sh. Goey et al., INTRAPLEURAL ADMINISTRATION OF INTERLEUKIN-2 IN PLEURAL MESOTHELIOMA - A PHASE I-II STUDY, British Journal of Cancer, 72(5), 1995, pp. 1283-1288
Authors:
VROUENRAETS BC
KLAASE JM
KROON BBR
VANGEEL BN
EGGERMONT AMM
FRANKLIN HR
Citation: Bc. Vrouenraets et al., LONG-TERM MORBIDITY AFTER REGIONAL ISOLATED PERFUSION WITH MELPHALAN FOR MELANOMA OF THE LIMBS - THE INFLUENCE OF ACUTE REGIONAL TOXIC REACTIONS, Archives of surgery, 130(1), 1995, pp. 43-47
Authors:
KLAASE JM
KROON BBR
VANGEEL AN
VANWIJK J
FRANKLIN HR
EGGERMONT AMM
HART AAM
Citation: Jm. Klaase et al., LIMB RECURRENCE-FREE INTERVAL AND SURVIVAL IN PATIENTS WITH RECURRENTMELANOMA OF THE EXTREMITIES TREATED WITH NORMOTHERMIC ISOLATED PERFUSION, Journal of the American College of Surgeons, 178(6), 1994, pp. 564-572
Authors:
KAPTEIJN BAE
KLAASE JM
VANGEEL AN
EGGERMONT AMM
KROON BBR
Citation: Bae. Kapteijn et al., RESULTS OF REGIONAL ISOLATED PERFUSION FOR LOCALLY INOPERABLE MELANOMA OF THE LIMBS, Melanoma research, 4(2), 1994, pp. 135-138
Authors:
KLAASE JM
KROON BBR
VANGEEL AN
EGGERMONT AMM
FRANKLIN HR
VANDONGEN JA
Citation: Jm. Klaase et al., IS THERE AN INDICATION FOR A DOUBLE PERFUSION SCHEDULE WITH MELPHALANFOR PATIENTS WITH RECURRENT MELANOMA OF THE LIMBS, Melanoma research, 4, 1994, pp. 13-16
Authors:
LIENARD D
EGGERMONT AMM
KOOPS HS
KROON BBR
ROSENKAIMER F
AUTIER P
LEJEUNE FJ
Citation: D. Lienard et al., ISOLATED PERFUSION OF THE LIMB WITH HIGH-DOSE TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA), INTERFERON-GAMMA (IFN-GAMMA) AND MELPHALAN FOR MELANOMA STAGE-III - RESULTS OF A MULTICENTER PILOT-STUDY, Melanoma research, 4, 1994, pp. 21-26
Authors:
KUPPEN PJK
EGGERMONT AMM
QUAK RBWM
MARINELLI A
VANDEVELDE CJH
FLEUREN GJ
Citation: Pjk. Kuppen et al., SOLUBLE FACTORS PRODUCED BY MACROPHAGES MONOCYTES INHIBIT LYMPHOKINE-ACTIVATED KILLER ACTIVITY IN RAT SPLENOCYTE CULTURES, Cancer immunology and immunotherapy, 38(1), 1994, pp. 61-67
Authors:
VANDEVRIE W
JONKER AM
MARQUET RL
EGGERMONT AMM
Citation: W. Vandevrie et al., THE CHEMOSENSITIZER CYCLOSPORINE-A ENHANCES THE TOXIC SIDE-EFFECTS OFDOXORUBICIN IN THE RAT, Journal of cancer research and clinical oncology, 120(9), 1994, pp. 533-538
Authors:
CLAASEN HHV
EGGERMONT AMM
NOOYEN YA
WARNAAR SO
FLEUREN GJ
Citation: Hhv. Claasen et al., IMMUNOTHERAPY IN A HUMAN OVARIAN-CANCER XENOGRAFT MODEL WITH 2 BISPECIFIC MONOCLONAL-ANTIBODIES - OV-TL3 CD3 AND OC/TR/, Gynecologic oncology, 52(2), 1994, pp. 199-206
Authors:
KLAASE JM
KROON BBR
VANGEEL AN
EGGERMONT AMM
FRANKLIN HR
HART AAM
Citation: Jm. Klaase et al., PROGNOSTIC FACTORS FOR TUMOR RESPONSE AND LIMB RECURRENCE-FREE INTERVAL IN PATIENTS WITH ADVANCED MELANOMA OF THE LIMBS TREATED WITH REGIONAL ISOLATED PERFUSION WITH MELPHALAN, Surgery, 115(1), 1994, pp. 39-45